CompletedObservationalLast updated Apr 15, 2022

Malignant Hyperthermia in Czech Republic: Description of the Biggest Slavonic Group of Patients Investigated for Risk of Malignant Hyperthermia

Malignant Hyperthermia in Czech Republic: Description of the Biggest Slavonic Group of Patients Investigated for Risk of Malignant Hyperthermia (MH): Retrospective MH Registry Analysis

Overview

ClinicalTrials.gov ID: NCT05036148
Lead Sponsor: Brno University HospitalOTHER
Brief Summary: The Academic centre for Malignant Hyperthermia of Masaryk University (ACMHMU) was established in 2021 in Brno, Czech Republic and consists of four academic departments of Medical Faculty of Masaryk University in two tertiary university hospitals, University Hospital Brno and St. Anne Faculty Hospital. These departments collaborated and operated since 2002 and since 2019 is Brno one of the of centre of EMHG (www.emhg.org). Aim of this study was to describe the Czech and Slovak (CZ-SK) cohort of MHS patients, the biggest Slavonic MHS cohort known by now, and to fill the knowledge gap about the Slavonic population in perspective of MH.

Status

Overall Status: Completed
Start Date: Sep 1, 2021Actual
Primary Completion Date: Dec 31, 2021Actual
Completion Date: Dec 31, 2021Actual

Study Record Dates

First Submitted: Jul 27, 2021
First Submitted that Met QC Criteria: Aug 30, 2021
First Posted: Sep 5, 2021Actual
Last Update Submitted that Met QC Criteria: Apr 14, 2022
Last Update Posted: Apr 15, 2022Actual
Last Verified: Apr 2022

NCT04287556Unknown status

Population at Risk of Malignant Hyperthermia: Ambispective Cohort.

NCT05402839Recruiting

Screening of Malignant Hyperthermia Susceptible Individuals

NCT02561598Withdrawn

A Case Control Study of Patients With Diagnosis of Malignant Hyperthermia

NCT04474860Unknown status

Gene Mutation Spectrum of Malignant Hyperthermia in China

NCT03964870Unknown status

Spanish Registry of RYR1 and CACNA1S Polymorphisms

NCT02964481Terminated

Malignant Hyperthermia Registry and Genetic Testing